Intravascular cell replacement therapy for stroke

被引:60
作者
Guzman, Raphael [1 ]
Choi, Raymond [1 ]
Gera, Atul [1 ]
Angeles, Alejandro De Los [1 ]
Andres, Robert H. [1 ]
Steinberg, Gary K. [1 ]
机构
[1] Stanford Univ, Med Ctr, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA
关键词
intravascular cell delivery; neuroprotection; regenerative medicine; stem cells; stroke;
D O I
10.3171/FOC/2008/24/3-4/E14
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The use of stem cell transplantation to restore neurological function after stroke is being recognized as a potential novel therapy. Before stem cell transplantation can become widely applicable, however, questions remain about the optimal site of delivery and timing of transplantation. In particular, there seems to be increasing evidence that intravascular cell delivery after stroke is a viable alternative to intracerebral transplantation. In this review, the authors focus on the intravascular delivery of stem cells for stroke treatment with an emphasis on timing, transendothelial migration and possible mechanisms leading to neuroprotection, angiogenesis, immunomodulation, and neural plasticity. They also review current concepts of in vivo imaging and tracking of stem cells after stroke.
引用
收藏
页数:10
相关论文
共 100 条
[1]  
Adams JC, 2000, DEV DYNAM, V218, P280
[2]   Neuronal replacement from endogenous precursors in the adult brain after stroke [J].
Arvidsson, A ;
Collin, T ;
Kirik, D ;
Kokaia, Z ;
Lindvall, O .
NATURE MEDICINE, 2002, 8 (09) :963-970
[3]   Neuroprotection in ischemia-reperfusion injury: An antiinflammatory approach using a novel broad-spectrum chemokine inhibitor [J].
Beech, JS ;
Reckless, J ;
Mosedale, DE ;
Grainger, DJ ;
Williams, SCR ;
Menon, DK .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (06) :683-689
[4]   Chemokines regulate the migration of neural progenitors to sites of neuroinflammation [J].
Belmadani, A ;
Tran, PB ;
Ren, DJ ;
Miller, RJ .
JOURNAL OF NEUROSCIENCE, 2006, 26 (12) :3182-3191
[5]   Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke [J].
Blann, A ;
Kumar, P ;
Krupinski, J ;
McCollum, C ;
Beevers, DG ;
Lip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (05) :277-284
[6]   Cell transplantation therapy for stroke [J].
Bliss, Tonya ;
Guzman, Raphael ;
Daadi, Marcel ;
Steinberg, Gary K. .
STROKE, 2007, 38 (02) :817-826
[7]   Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke [J].
Borlongan, CV ;
Hadman, M ;
Sanberg, CD ;
Sanberg, PR .
STROKE, 2004, 35 (10) :2385-2389
[8]   In vivo magnetic resonance tracking of magnetically labeled cells after transplantation [J].
Bulte, JWM ;
Duncan, ID ;
Frank, JA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (08) :899-907
[9]   Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination [J].
Bulte, JWM ;
Zhang, SC ;
van Gelderen, P ;
Herynek, V ;
Jordan, EK ;
Duncan, ID ;
Frank, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15256-15261
[10]   Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats [J].
Chen, JL ;
Sanberg, PR ;
Li, Y ;
Wang, L ;
Lu, M ;
Willing, AE ;
Sanchez-Ramos, J ;
Chopp, M .
STROKE, 2001, 32 (11) :2682-2688